PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Paediatrics and Child Health, University of Otago Wellington, PO Box 7343, Wellington South 6242, New Zealand; Department of Paediatrics and Child Health, Capital and Coast District Health Board, Wellington 7902, New Zealand. Electronic address: esko.wiltshire@otago.ac.nz.\', \'Robinson Research Institute and Discipline of Paediatrics, University of Adelaide, North Adelaide, South Australia 5006, Australia; Endocrinology and Diabetes Centre, Women\'s and Children\'s Hospital, North Adelaide, South Australia 5006, Australia.\', \'Department of Paediatrics, University of Otago Christchurch, Christchurch, New Zealand; Department of Paediatrics, Canterbury District Health Board, Christchurch, New Zealand.\', \'Department of Anaesthesia, University of Otago Christchurch, Christchurch, New Zealand; Department of Intensive Care, Canterbury District Health Board, Christchurch, New Zealand.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0306-9877(20)32195-210.1016/j.mehy.2020.110142
?:doi
?:hasPublicationType
?:journal
  • Medical hypotheses
is ?:pmid of
?:pmid
?:pmid
  • 32759013
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.443
?:rankingScore_hIndex
  • 75
is ?:relation_isRelatedTo_publication of
?:title
  • High dose folic acid is a potential treatment for pulmonary hypertension, including when associated with COVID-19 pneumonia.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all